An integrated, specialty healthcare company.

Concordia is an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products. Concordia trades on the NASDAQ Global Select Market® under the symbol CXRX, and on the Toronto Stock Exchange under the symbol CXR.

  • View Stock Information

  • View Stock Information

  • Latest News

  • Downloads

    CBCA Recapitalization Document – Preliminary Interim Order

    CBCA Recapitalization Document – Motion Record Volume 1

    CBCA Recapitalization Document – Motion Record Volume 2

    Concordia International DELIVER Presentation

    DELIVER Fact Sheet

    2017 Third Quarter Report

    2017 Second Quarter Report

    2017 First Quarter Report

    2016 Annual Report

    2016 Third Quarter Report

    2016 Second Quarter Report


    View Financials

  • Events

  • Investor Relations

    For investor-related queries, please contact:

    1 905 842 5150